NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial
Status:
Not yet recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
In this Phase III clinical trial, researchers evaluate the efficacy and safety of NW
Roselle®, a powdered medicinal product developed by Natural Wellness. NW Roselle combines
extracts from Hibiscus Sabdariffa (HS) flowers and Olea europaea (OE) leaves. The trial aims
to gather evidence on the efficacy and safety of NW Roselle as a potential treatment option
for Grade 1 essential hypertension.